Michelle Willicombe

InstitutionDepartment of Immunology and Inflammation
AddressLondon
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 24 Covid-19 publications, with a maximum of 4 publications in March 2021
    All Publications
    Bar chart showing 48 publications over 13 distinct years, with a maximum of 16 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Carr EJ, Wu M, Harvey R, Wall EC, Kelly G, Hussain S, Howell M, Kassiotis G, Swanton C, Gandhi S, Bauer DL, Billany RE, Graham-Brown MP, Beckett J, Bull K, Shankar S, Henderson S, Motallebzadeh R, Salama AD, Harper L, Mark PB, McAdoo S, Willicombe M, Beale R. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. 2021 09 18; 398(10305):1038-1041. PMID: 34391504.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    2. Prendecki M, Clarke C, Edwards H, McIntyre S, Mortimer P, Gleeson S, Martin P, Thomson T, Randell P, Shah A, Singanayagam A, Lightstone L, Cox A, Kelleher P, Willicombe M, McAdoo SP. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression. Ann Rheum Dis. 2021 10; 80(10):1322-1329. PMID: 34362747.
      Citations: 16     Fields:    Translation:HumansCells
    3. Medjeral-Thomas NR, Troldborg A, Hansen AG, Pihl R, Clarke CL, Peters JE, Thomas DC, Willicombe M, Palarasah Y, Botto M, Pickering MC, Thiel S. Protease inhibitor plasma concentrations associate with COVID-19 infection. Oxf Open Immunol. 2021; 2(1):iqab014. PMID: 34458849.
      Citations:    
    4. Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep. 2021 Sep; 6(9):2292-2304. PMID: 34250319.
      Citations: 8     
    5. Prendecki M, Willicombe M. Single-dose SARS-CoV-2 vaccination efficacy in the elderly. Lancet Infect Dis. 2021 11; 21(11):1474-1475. PMID: 34174192.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Medjeral-Thomas NR, Troldborg A, Hansen AG, Gisby J, Clarke CL, Prendecki M, McAdoo SP, Sandhu E, Lightstone L, Thomas DC, Willicombe M, Botto M, Peters JE, Pickering MC, Thiel S. Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease. Front Immunol. 2021; 12:671052. PMID: 33995410.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    7. Vergis N, Phillips R, Cornelius V, Katsarou A, Youngstein T, Cook L, Willicombe M, Pilay C, Shturova T, Almonte M, Charania A, Turner R, Kon OM, Cooke G, Thursz M, Cherlin S, Wason J, Milojkovic D, Innes AJ, Cooper N. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 12; 22(1):270. PMID: 33845867.
      Citations: 2     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    8. Gulati K, Prendecki M, Clarke C, Willicombe M, McAdoo S. COVID-19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021 06; 73(6):1091-1092. PMID: 33512093.
      Citations: 3     Fields:    Translation:Humans
    9. Clarke CL, Prendecki M, Dhutia A, Gan J, Edwards C, Prout V, Lightstone L, Parker E, Marchesin F, Griffith M, Charif R, Pickard G, Cox A, McClure M, Tedder R, Randell P, Greathead L, Guckian M, McAdoo SP, Kelleher P, Willicombe M. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int. 2021 06; 99(6):1470-1477. PMID: 33774082.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    10. Gleeson S, Martin P, Bedi R, Lynch K, Willicombe M, Lightstone L. Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program. Kidney Int. 2021 05; 99(5):1238-1239. PMID: 33892859.
      Citations:    Fields:    Translation:HumansPHPublic Health
    11. Gisby J, Clarke CL, Medjeral-Thomas N, Malik TH, Papadaki A, Mortimer PM, Buang NB, Lewis S, Pereira M, Toulza F, Fagnano E, Mawhin MA, Dutton EE, Tapeng L, Richard AC, Kirk PD, Behmoaras J, Sandhu E, McAdoo SP, Prendecki MF, Pickering MC, Botto M, Willicombe M, Thomas DC, Peters JE. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death. Elife. 2021 03 11; 10. PMID: 33704068.
      Citations: 4     Fields:    Translation:Humans
    12. Thind AK, Beckwith H, Dattani R, Dhutia A, Gleeson S, Martin P, Ryan L, Shuaib R, Svetitsky S, Dor FJMF, Brown EA, Willicombe M. Resuming Deceased Donor Kidney Transplantation in the COVID-19 Era: What Do Patients Want? Transplant Direct. 2021 Apr; 7(4):e678. PMID: 33688577.
      Citations:    
    13. Prendecki M, Clarke C, Brown J, Cox A, Gleeson S, Guckian M, Randell P, Pria AD, Lightstone L, Xu XN, Barclay W, Barclay W, McAdoo SP, Kelleher P, Willicombe M. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. Lancet. 2021 03 27; 397(10280):1178-1181. PMID: 33640037.
      Citations: 63     Fields:    Translation:HumansCells
    14. Turner-Stokes T, Jiang E, Johnson N, Khakhria K, Kong E, Cairns T, Clarke C, Greathead L, Griffith M, Guckian M, Kelleher P, McClure MO, Prendecki M, Rosadas C, Tedder R, Lightstone L, Willicombe M, McAdoo SP. Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease. Kidney Int Rep. 2021 May; 6(5):1402-1406. PMID: 33615050.
      Citations:    
    15. Mamode N, Ahmed Z, Jones G, Banga N, Motallebzadeh R, Tolley H, Marks S, Stojanovic J, Khurram MA, Thuraisingham R, Popoola J, Ghazanfar A, Game D, Sran K, Dor FJMF, Lucisano G, Sinha M, Olsburgh J, Willicombe M. Mortality Rates in Transplant Recipients and Transplantation Candidates in a High-prevalence COVID-19 Environment. Transplantation. 2021 01 01; 105(1):212-215. PMID: 33196624.
      Citations: 9     Fields:    Translation:Humans
    16. Willicombe M, Gleeson S, Clarke C, Dor F, Prendecki M, Lightstone L, Lucisano G, McAdoo S, Thomas D. Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening. Transplantation. 2021 01 01; 105(1):151-157. PMID: 33196625.
      Citations: 5     Fields:    Translation:Humans
    17. Prendecki M, Clarke C, McKinnon T, Lightstone L, Pickering MC, Thomas DC, McAdoo SP, Willicombe M. SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19. Kidney Med. 2021 Jan-Feb; 3(1):54-59.e1. PMID: 33521621.
      Citations: 2     
    18. Clarke C, Lucisano G, Prendecki M, Gleeson S, Martin P, Ali M, McAdoo SP, Lightstone L, Ashby D, Charif R, Griffith M, McLean A, Dor F, Willicombe M. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era. Kidney Int Rep. 2021 Jan; 6(1):46-55. PMID: 33173838.
      Citations: 9     
    19. Prendecki M, Clarke C, Gleeson S, Greathead L, Santos E, McLean A, Randell P, Moore LSP, Mughal N, Guckian M, Kelleher P, Mcadoo SP, Willicombe M. Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients. J Am Soc Nephrol. 2020 12; 31(12):2753-2756. PMID: 33122285.
      Citations: 13     Fields:    Translation:Humans
    20. Prendecki M, Clarke C, Medjeral-Thomas N, McAdoo SP, Sandhu E, Peters JE, Thomas DC, Willicombe M, Botto M, Pickering MC. Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression. Clin Kidney J. 2020 Oct; 13(5):889-896. PMID: 33123364.
      Citations: 9     
    21. Clarke CL, Prendecki M, McAdoo SP, Willicombe M. Authors' Reply. J Am Soc Nephrol. 2020 12; 31(12):2967-2968. PMID: 33001841.
      Citations:    Fields:    Translation:HumansPHPublic Health
    22. Clarke C, Prendecki M, Dhutia A, Ali MA, Sajjad H, Shivakumar O, Lightstone L, Kelleher P, Pickering MC, Thomas D, Charif R, Griffith M, McAdoo SP, Willicombe M. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. J Am Soc Nephrol. 2020 09; 31(9):1969-1975. PMID: 32732391.
      Citations: 48     Fields:    Translation:HumansCellsPHPublic Health
    23. Prendecki M, Clarke C, Cairns T, Cook T, Roufosse C, Thomas D, Willicombe M, Pusey CD, McAdoo SP. Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int. 2020 09; 98(3):780-781. PMID: 32599088.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    24. Willicombe M, Thomas D, McAdoo S. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? J Am Soc Nephrol. 2020 Jun; 31(6):1145-1146. PMID: 32312797.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    Willicombe's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (88)
    Explore
    _
    Co-Authors (163)
    Explore
    _
    Similar People (60)
    Explore
    _